Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
October 30, 2004
Palladium-catalyzed asymmetric allylic alkylation of ketone enolates
Barry M Trost, Gretchen M Schroeder
Journal of the American Chemical Society
|
March 3, 2005
Total synthesis of (+)-allocyathin B2
Barry M Trost, Li Dong, Gretchen M Schroeder
Journal of the American Chemical Society
|
July 21, 2005
Exploiting the Pd- and Ru-catalyzed cycloisomerizations: enantioselective total synthesis of (+)-allocyathin B2
Barry M Trost, Li Dong, Gretchen M Schroeder
Organic Letters
|
September 27, 2002
Intramolecular palladium-catalyzed allylic alkylation: enantio- and diastereoselective synthesis of [2.2.2] bicycles
Barry M Trost, Karna L Sacchi, Gretchen M Schroeder, et al.
Journal of the American Chemical Society
|
April 9, 2004
An asymmetric synthesis of hamigeran B via a Pd asymmetric allylic alkylation for enantiodiscrimination
Barry M Trost, Carole Pissot-Soldermann, Irwin Chen, et al.
Drug Discovery Today
|
November 19, 2013
Antibody-drug conjugates: current status and future directions
Heidi L Perez, Pina M Cardarelli, Shrikant Deshpande, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor
Brooke M Katzman, Bryan D Cox, Anthony R Prosser, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 6, 2017
Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads
Andrew F Donnell, Yong Zhang, Erik M Stang, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2018
Discovery of <i>N</i>-Alkyl Piperazine Side Chain Based CXCR4 Antagonists with Improved Drug-like Properties
Yesim A Tahirovic, Valarie M Truax, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters
|
January 20, 2018
Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists
Robert J Wilson, Edgars Jecs, Eric J Miller, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
October 30, 2004
Palladium-catalyzed asymmetric allylic alkylation of ketone enolates
Barry M Trost, Gretchen M Schroeder
Journal of the American Chemical Society
|
March 3, 2005
Total synthesis of (+)-allocyathin B2
Barry M Trost, Li Dong, Gretchen M Schroeder
Journal of the American Chemical Society
|
July 21, 2005
Exploiting the Pd- and Ru-catalyzed cycloisomerizations: enantioselective total synthesis of (+)-allocyathin B2
Barry M Trost, Li Dong, Gretchen M Schroeder
Organic Letters
|
September 27, 2002
Intramolecular palladium-catalyzed allylic alkylation: enantio- and diastereoselective synthesis of [2.2.2] bicycles
Barry M Trost, Karna L Sacchi, Gretchen M Schroeder, et al.
Journal of the American Chemical Society
|
April 9, 2004
An asymmetric synthesis of hamigeran B via a Pd asymmetric allylic alkylation for enantiodiscrimination
Barry M Trost, Carole Pissot-Soldermann, Irwin Chen, et al.
Drug Discovery Today
|
November 19, 2013
Antibody-drug conjugates: current status and future directions
Heidi L Perez, Pina M Cardarelli, Shrikant Deshpande, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor
Brooke M Katzman, Bryan D Cox, Anthony R Prosser, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 6, 2017
Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads
Andrew F Donnell, Yong Zhang, Erik M Stang, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2018
Discovery of <i>N</i>-Alkyl Piperazine Side Chain Based CXCR4 Antagonists with Improved Drug-like Properties
Yesim A Tahirovic, Valarie M Truax, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters
|
January 20, 2018
Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists
Robert J Wilson, Edgars Jecs, Eric J Miller, et al.
Page
of 3